Young Lag Cho
12Patents
2h-index
39Co-inventors
50Inventor score
Filing activity: May 9, 2008 → Mar 9, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8329684B2 | Cephalosporin derivatives and pharmaceutical compositions thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US8178525B2 | FXA inhibitors with cyclic amidoxime or cyclic amidrazone as P4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof | Chemistry; Metallurgy | 3 | Active |
| US8242113B2 | Oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone pharmaceutical compositions thereof | Human Necessities | 2 | Active |
| US9630977B2 | Cephalosporin derivatives and pharmaceutical compositions thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US8637667B2 | Method for preparing (S)-5-chloro-N-((3-(4-(5,6-dihydro-4H-1,2,4-oxadiazin-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide derivatives | Chemistry; Metallurgy | 1 | Active |
| US9951072B2 | Compositions and methods for inhibiting beta-lactamase | Chemistry; Metallurgy | 1 | Active |
| US8754210B2 | Method for preparing 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl) derivative and intermediate used therein | Chemistry; Metallurgy | 1 | Active |
| US8703939B2 | Method for preparing (R)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1H)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivatives | Chemistry; Metallurgy | 0 | Active |
| US10273235B2 | Compositions and methods for inhibiting β-lactamase | Chemistry; Metallurgy | 0 | Active |
| US8846669B2 | Oxazolidinone derivative and medical composition containing same | Human Necessities | 0 | Active |
| US8288423B2 | FXa inhibitors with cyclic amidines as P4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof | Human Necessities | 0 | Active |
| US9988372B2 | Crystalline form of 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide methanesulfonate and pharmaceutical composition comprising same | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.